July 13 (Reuters) – Cosmos Health Inc: * COSMOS HEALTH ACCELERATES PRESCRIPTION MEDICINE STRATEGY WITH LIBYTEC PARTNERSHIP TO COMMERCIALIZE DIABIT-IS X IN GREECE * COSMOS HEALTH – ENTERS FIVE-YEAR
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)